OPAM Workshop: Basic Course in Occupational and Environmental Medicine, Part III-306850

Video Transcription

Video Summary

Dr. Al Baltracitis, an expert in occupational medicine, discusses the impact of workplace substances on fertility and pregnancy outcomes. He introduces the challenges posed by electronic health records, which detract from patient interactions. The focus then shifts to how workplace exposures impact reproductive health, highlighting substances like dibromochloropropane (DBCP) and lead. Dr. Baltracitis reviews fertility in both men and women and the effects of various teratogens, emphasizing issues like spontaneous abortions and congenital anomalies. He references historical cases, such as the impact of DBCP on Nicaraguan workers and the Minamata disease due to mercury poisoning. Legal cases concerning reproductive health, including UAW vs. Johnson Controls and Young vs. UPS, are discussed to underscore employer responsibilities regarding pregnancy and hazardous workplace conditions. Recommendations for workplace accommodations for pregnant workers and the need for employers to comply with safety regulations and provide proper PPE are emphasized. The presentation underlines the significance of reducing exposure levels to ensure the safety of both male and female reproductive health, while also stressing the need for sensitive handling of employee concerns.

Keywords

occupational medicine

workplace substances

fertility

pregnancy outcomes

reproductive health

teratogens

legal cases

workplace accommodations

safety regulations